Rapid growth of population is very dynamic as it depends
upon the physiologic processes that undergoes drug disposition and rapid
changes in pediatrics. Pharmacological consideration requires the
specifications in pediatric patients. During administering general anesthesia
to children, the surgeons should have a brief knowledge on pharmacologic,
physiological differences between the adults and infants.
General
Anesthesia
The immediately before, during, and after surgery (perioperative
period) immediately is a critical time for pediatric patients. Medications
provides a blunt physiologic response and render patients unaware of what is
being done to or around them. The increased risk for mortality and morbidity in
the perioperative period demands the utmost vigilance. Such risks may be
increased in certain disease states. The purpose of general
anesthesia is to suppress the conscious perception of, and physiologic
response to, noxious stimuli and to render the patient unconscious.
Phases of Anesthesia are:
·
Preanesthetic Phase
·
Induction Phase
·
Maintenance Phase
·
Reversal Phase
Preanesthetic
Phase: Numerous classes of medications can be given to children as
anticholinergics, histamine blockers, sedatives, analgesics,) during the
preanesthetic phase. The phase ensures that the patient arrives in the
operating room in a relaxed manner, calm without compromised breathing or
impaired cardiovascular status.
Induction
Phase: General anesthesia is induced with either inhalation or
intravenous (IV) medications. In most instances, the volatile anesthetic
agents are preferred in children over IV medications because they do not
require IV access. IV medications are used to induce anesthesia in children
only in rare circumstances mostly in case of hyperthermia.
Maintenance
Phase: This phase is the period between induction and emergence.
During this time, the child should be asleep, hemodynamic responses to painful
stimuli, and homeostatically supported Neuromuscular blockers are used during muscle
paralysis is needed.
Reversal
Phase: The volatile inhalation agents rapidly leave the lungs
during ventilation and thus do not require other products to reverse their
actions.
The above phases are administered for the treatment in
infants and pediatric patients.